SPOTLIGHT -
Overcoming Challenges in Treating MCL
Jonathon B. Cohen, MD, discusses the biggest challenge in treating mantle cell lymphoma and how these challenges can be overcome.
Promising Results for Bendamustine/Rituximab Plus Polatuzumab Vedotin in Lymphomas
Jonathon B. Cohen, MD, discusses findings from a study of polatuzumab vedotin, an anti-CD79b antibody-drug conjugate, with bendamustine and rituximab in patients with aggressive lymphomas.